BioNTech SE annual gross profit
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioNTech SE Gross Profit Growth & History (BNTX)
BioNTech SE's gross profit was €2.23B for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.23B | €18.3M | +0.83% |
| 2024 | 2024-12-31 | €2.21B | −€1.01B | −31.36% |
| 2023 | 2023-12-31 | €3.22B | −€11.10B | −77.51% |
| 2022 | 2022-12-31 | €14.32B | −€1.75B | −10.89% |
| 2021 | 2021-12-31 | €16.07B | €15.64B | +3697.92% |
| 2020 | 2020-12-31 | €423.0M | €331.8M | +363.67% |
| 2019 | 2019-12-31 | €91.2M | −€22.7M | −19.89% |
| 2018 | 2018-12-31 | €113.9M | €61.6M | +117.84% |
| 2017 | 2017-12-31 | €52.3M | — | — |
BioNTech SE gross profit trends
Over the last five fiscal years, BioNTech SE's gross profit increased from €423.0M to €2.23B, a change of €1.81B.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗